Science, Politics And The Pharmaceutical Industry: Controversy And Bias In Drug Regulation - Image 1

£49.34

Routledge Science, Politics And The Pharmaceutical Industry: Controversy And Bias In Drug Regulation

Name: Science, Politics And The Pharmaceutical Industry: Controversy And Bias In Drug Regulation
Brand: Routledge
Price: 49.34 GBP
Availability: InStock

Medical, Legal & Social Sciences

This is the most expensive it has ever been. Walk away.

£49 today · previous high £49 · all-time low £40

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 637 days • 637 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 637 days • 6 price levels

Days at Price

Current Price

Price Analysis

Most common price: £44 (320 days, 50.2%)

Price range: £40 - £49

Price levels: 6 different prices over 637 days

Description

Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in order to probe deeply into the work of scientists in the pharmaceutical industry and governmental drug regulatory authorities on both sides of the Atlantic. Through the examination of contemporary controversial case studies, he exposes how the commercial interest of drug manufacturers are consistently given the benefit of the scientific doubts about medicine safety and effectiveness, over and above the best interests of patients.; A highly original combination of philosophical rigour, historical sensitivity and empirical depth enables the "black box" of industrial and government science to be opened up to critical scrutiny much more than in previous social scientific study. All major aspects of drug testing and regulation are considered, including pre- clinical animal tests, clinical trials and postmarketing surveillance of adverse drug reactions. The author argues that drug regulators are too dependent on pharmaceutical industry resources and expertise, and too divorced from public accountability. The problem of corporate bias is particularly severe in the UK, where regulatory decisions about medicine safety are shrouded in greater secrecy than in the US.; Since the purpose of drug regulation should be to maximize the safety and effectiveness of medicines for patients, the public needs and deserves policies to counteract corporate bias in drug testing and evaluation. John Abraham's realist analysis provides a robust basis for policy interventions at the institutional and legislative levels. He proposes that corporate bias could be reduced by more extensive freedom of information, greater autonomy of government scientists from pharmaceutical industry, the development of independent drug testing by the regulatory authority, increased patient representation on regulatory committees, and more frequent and thorough oversight of regulatory performance by the legislature. This book should be of interest to anyone who cares about how medicines should be controlled in modern society. It should prove particularly rewarding for students and researchers in the sociology of science and technology, science and medicines policy, medical sociologists, the medical and pharmaceutical professions, and consumer organizations.

Product Specifications

Brand: Routledge
Format: paperback
ASIN: 1857282000
Category: Books > Subjects > Biography > Medical, Legal & Social Sciences
Domain: Amazon UK
Release Date: 29 June 1995
Listed Since: 05 February 2007

Barcode

No barcode data available

Routledge Science, Politics And The Pharmaceutical Industry: Controversy And Bias In Drug Regulation

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drug Control and International Law (Routledge Research in International Law)

Legal Medicine 1985

Analysis of Drugs of Abuse: 1810 (Methods in Molecular Biology, 1810)

Forschung wider Willen?: Rechtsprobleme biomedizinischer Forschung mit nichteinwilligungsfähigen Personen (MedR Schriftenreihe Medizinrecht)

Drugs and Drug Policy: The Control of Consciousness Alteration

Artificial Intelligence in Drug Development: Patenting and Regulatory Aspects (Frontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications)

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Humana Practical Protein Chromatography - Methods in Molecular Biology

The 2027-2032 World Outlook for Biotechnology Reagents

How Medicines Work: Illustrated

Chembiomolecular Science: At the Frontier of Chemistry and Biology

Managing the Drug Discovery Process: Insights and advice for students, educators, and practitioners

Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring: A Comprehensive Guide

Drug Testing: Issues and Options

Advances in Chromatographic Techniques for Therapeutic Drug Monitoring

Statistical Issues in Drug Development (Statistics in Practice)

Humana Optimization in Drug Discovery: In Vitro Methods Book

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Guide to EU and UK Pharmaceutical Regulatory Law

Overcoming Obstacles in Drug Discovery and Development: Surmounting the Insurmountable―Case Studies for Critical Thinking

Lipid-Based Nanocarriers for Drug Delivery and Diagnosis (Micro and Nano Technologies)